April 16, 2013

This is going to be a big year for community pharmacy, said Thrifty White president and CEO Bob Narveson, as the nation reaches full implementation of the Patient Protection and Affordable Care Act in 2014. “But to be successful, we are going to have to maintain access to those patients,” Narveson told DSNTV last month in a frank and broad-ranging discussion about the state of the industry, the role community pharmacy can play in healthcare reform, and how NACDS member companies like his own are innovating patient care, driving improved outcomes and lowering costs.

June 3, 2014

Sandoz on Tuesday announced an agreement with Upsher-Smith to obtain exclusive U.S. distribution rights for its branded potassium chloride line of products, Klor-Con, and market them under the Sandoz name.

March 12, 2014

Upsher-Smith has received approval from the Food and Drug Administration for Qudexy XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic profile.